Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-J Body

Showing results (141-150 of 213) with videos related to

Pageof 22
Sort By:
British Journal of Cancer|September 19, 2007
Increased Dickkopf-1 expression in breast cancer bone metastasesN Voorzanger-Rousselot, D Goehrig, F Journe, et al.
Climacteric : the Journal of the International Menopause Society|November 22, 2021
Impact of non-hip fractures in elderly women: a narrative reviewA Charles, A Mugisha, L Iconaru, et al.
Calcified Tissue International|March 22, 2022
Distribution of Fracture Sites in Postmenopausal Overweight and Obese Women: The FRISBEE StudyA Charles, A Mugisha, L Iconaru, et al.
JBMR Plus|December 18, 2019
Does the Prediction Accuracy of Osteoporotic Fractures by BMD and Clinical Risk Factors Vary With Fracture Site?L Iconaru, M Moreau, V Kinnard, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 4, 2023
Are there specific clinical risk factors for the occurrence of multiple fractures? The FRISBEE studyA Charles, L Iconaru, F Baleanu, et al.
Bone Reports|May 9, 2020
What is the validity of self-reported fractures?F Baleanu, M Moreau, V Kinnard, et al.
Bone Reports|February 24, 2023
The effect of fracture recency on observed 5-year fracture probability: A study based on the FRISBEE cohortL Iconaru, A Charles, F Baleanu, et al.
Cancer Treatment Reviews|November 19, 2016
Bone health in the elderly cancer patient: A SIOG position paperJ J Body, E Terpos, B Tombal, et al.
Clinical Rheumatology|June 1, 1997
Prevention and treatment of postmenopausal osteoporosis. National Consensus of the "Belgian Bone Club", November 1996J M Kaufman, J P Devogelaer, F Raeman, et al.
Clinical Therapeutics|October 4, 2005
Cost-effectiveness of oral ibandronate versus IV zoledronic acid or IV pamidronate for bone metastases in patients receiving oral hormonal therapy for breast cancer in the United KingdomErwin De Cock, John Hutton, Peter Canney, et al.
Pageof 22

Showing results (141-150 of 213) with videos related to

Sort By:
Pageof 22
British Journal of Cancer|September 19, 2007
Increased Dickkopf-1 expression in breast cancer bone metastasesN Voorzanger-Rousselot, D Goehrig, F Journe, et al.
Climacteric : the Journal of the International Menopause Society|November 22, 2021
Impact of non-hip fractures in elderly women: a narrative reviewA Charles, A Mugisha, L Iconaru, et al.
Calcified Tissue International|March 22, 2022
Distribution of Fracture Sites in Postmenopausal Overweight and Obese Women: The FRISBEE StudyA Charles, A Mugisha, L Iconaru, et al.
JBMR Plus|December 18, 2019
Does the Prediction Accuracy of Osteoporotic Fractures by BMD and Clinical Risk Factors Vary With Fracture Site?L Iconaru, M Moreau, V Kinnard, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 4, 2023
Are there specific clinical risk factors for the occurrence of multiple fractures? The FRISBEE studyA Charles, L Iconaru, F Baleanu, et al.
Bone Reports|May 9, 2020
What is the validity of self-reported fractures?F Baleanu, M Moreau, V Kinnard, et al.
Bone Reports|February 24, 2023
The effect of fracture recency on observed 5-year fracture probability: A study based on the FRISBEE cohortL Iconaru, A Charles, F Baleanu, et al.
Cancer Treatment Reviews|November 19, 2016
Bone health in the elderly cancer patient: A SIOG position paperJ J Body, E Terpos, B Tombal, et al.
Clinical Rheumatology|June 1, 1997
Prevention and treatment of postmenopausal osteoporosis. National Consensus of the "Belgian Bone Club", November 1996J M Kaufman, J P Devogelaer, F Raeman, et al.
Clinical Therapeutics|October 4, 2005
Cost-effectiveness of oral ibandronate versus IV zoledronic acid or IV pamidronate for bone metastases in patients receiving oral hormonal therapy for breast cancer in the United KingdomErwin De Cock, John Hutton, Peter Canney, et al.
Pageof 22